Neffy (epinephrine nasal spray) 1mg is approved for the emergency treatment of type 1 allergic reactions, including ...

Aquestive's Anaphylm, which is set for an imminent FDA filing, has blockbuster potential. See why I think AQST stock is a buy ...

Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.

An adrenaline rush is a colloquial expression about the feeling of exhilaration and heightened energy that is brought on by ...

Payment options are available based on insurance coverage. The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in children aged 4 ...

The maker of a new prescription drug product for people with life-threatening allergies is using copayment coupons to build ...

The U.S. Food and Drug Administration approved the local company’s 1 milligram dose of epinephrine nasal spray on Wednesday. It’s geared toward patients 4 years and older who weigh at least 33 ...

Cash Position & Operating Runway : As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments of $314.0 million, with 97,954,172 shares of common stock outstanding. The ...

Sophomores at Lynnfield High School presented their Civics Action projects to community members, who were welcomed into the ...

The US Food and Drug Administration (FDA) has approved Neffy, a nasal spray for treating severe allergic reactions in ...

Find the latest ARS Pharma news from Fast company. See related business and technology articles, photos, slideshows and videos.